Answers are grounded in this paper and cite their sources.
We report a case of anaplastic meningioma with extensive single-cell infiltration into the adjacent cerebral cortex in a pattern that histologically mimicked infiltrating glioma. This pattern of infiltration has not been previously described for a meningothelial tumour. Meningothelial differentiation was confirmed by histochemistry and electron microscopy. We also studied markers of epithelial–mesenchymal transition (EMT), all of which suggest a role for EMT in the aggressive clinical behaviour and extensive infiltration seen in this tumour. EMT, a biological process that allows polarized epithelial cells to assume a mesenchymal cell phenotype, has been implicated in malignant tumour progression. EMT is characterized by resistance to apoptosis and increased migratory capability.1 We evaluated several markers associated with EMT: E-cadherin (E-cad) and N-cadherin (N-cad), both of which are glycoproteins involved in calcium-dependent cell-cell adhesion;2 Twist, a basic helix–loop–helix transcription factor that is preferentially expressed in mesenchymal tissues;3 Snail, a transcription factor that down-regulates ectodermal genes within the mesoderm;4 and Slug, a transcription factor that down-regulates expression of genes with E-box motifs, including E-cad.5 Our patient was a 61-year-old male who presented with seizures. The neurological examination gave unremarkable findings, and the patient bore no stigmata of neurofibromatosis 2. MRI revealed a right frontotemporal dural-based lesion with radiographic features suggestive of an invasive en plaque meningioma. Complete surgical resection was attempted. The tumour was diagnosed by histopathology as an atypical meningioma (WHO grade II). The tumour recurred 4 years later, and was treated with surgery and adjuvant radiotherapy; the recurrent tumour was again histologically confirmed as atypical meningioma (WHO grade II) with extensive brain invasion. Three years after the second operation, the patient developed left-sided weakness. MRI showed tumour recurrence, prompting palliative surgery that included resection of the tumour and the subjacent abnormal-appearing cortex, which extended > 20 mm from grossly identifiable tumour. This second recurrence was diagnosed as an anaplastic meningioma (WHO grade III) by histopathology. The patient died following a complicated postoperative course. Sections from the first resection showed an atypical meningioma with increased mitotic activity [6/10 high-powered fields (HPFs)], small-cell change, prominent nucleoli, focal necrosis, and typical brain invasion by broad fingers of tumour into the cortex and along Virchow–Robin spaces around blood vessels. Sections from the second resection specimen also showed increased mitotic activity (13/10 HPFs), typical brain invasion, hypercellularity, prominent nucleoli, focal necrosis, nuclear atypia, and a sheet-like growth pattern. Sections from the third resection specimen showed an anaplastic meningioma with increased mitotic activity (23/10 HPFs), necrosis, hypercellularity, prominent nucleoli, and brain invasion (Figure 1A). In addition to the typical meningioma pattern of brain invasion, several centimetres of the adjacent cerebral cortex featured extensive single-cell infiltration by atypical, mitotically active cells (Figure 1B,C). We investigated this unusually infiltrative pattern. The infiltrating cells were glial fibrillary acidic protein-negative and vimentin-positive, and showed pericellular reticulin deposition (Figure 1D,E). Epithelial membrane antigen and pancytokeratin were negative throughout the tumour, including areas with typical meningioma morphology. The initial tumour and first recurrence were diffusely E-cad-immunoreactive. The second (anaplastic) recurrence entirely lacked E-cad immunoreactivity (Figure 2A). N-cad and Twist originally showed weak expression, but they showed increased expression in the first recurrence, and areas with strong diffuse membranous expression in the second recurrence (Figure 2B,C). Both of these markers also showed strong membranous expression in the atypical cells in the subjacent cortex (Figure 11–F–H), which were seen singly and in clusters. Snail and Slug also showed weak expression in the original tumour, increased expression in the first recurrence, and strong diffuse expression in the second anaplastic recurrence (Figure 2D,E). β-Catenin showed no abnormal nuclear localization in any of the three tumour occurrences. Electron microscopy was performed on the cortex, and showed single cells, occasionally in clusters, with extensive cellular processes and frequent tight junctions (Figure 1I,J). E-cad loss is associated with dedifferentiation and increased invasiveness in several malignancies, including meningioma. E-cad expression is often lost in cases with malignant progression from previously benign E-cad-expressing meningiomas.6 The extensive single-cell cortical invasion in this case is highly unusual, mimicking a pattern more typical of glioma. Knowledge of this pattern of extensive brain invasion may prevent diagnostic error in similar cases. Although the precise mechanism responsible for this extensive cortical infiltration is unclear, recent studies have suggested a diagnostic role for markers of EMT in meningiomas,7 and this case suggests the need for more rigorous study of the role of EMT in the pathogenesis of brain infiltration by meningiomas.
No takes yet. Share an insight, caveat, or question.
Celebre et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: